ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $343K of Ardelyx, Inc.
Sold$342,983
$6.92Price
49,564Shares
−9%Stake
What ARDX did after the filing
- The stock from Tue, Oct 1 close, $6.85
- −33.0%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Nov 12 close.
Traded Fri, Sep 27. Filed Tue, Oct 1, 12:34 PM ET, during the session. Returns use the Oct 1 close and the Nov 12 close. Not investment advice.